A carregar...

Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer

PURPOSE: Liposomal cisplatin was developed to reduce the systemic toxicity of cisplatin, particularly the nephrotoxicity, and it has been used in combination with other agents in pancreatic and head and neck cancers and non-small-cell lung cancer (NSCLC). Our objective was to compare the effectivene...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Stathopoulos, G. P., Antoniou, D., Dimitroulis, J., Stathopoulos, J., Marosis, K., Michalopoulou, P.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer-Verlag 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3180559/
https://ncbi.nlm.nih.gov/pubmed/21301848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-011-1572-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!